Healthcare Providers and Services
Company Overview of IHH Healthcare Berhad
IHH Healthcare Berhad provides healthcare services primarily in Asia, Central and Eastern Europe, the Middle East, and North Africa. It provides primary care services, including treatment of basic illnesses, routine check-ups, vaccination, and dental services. The company also offers secondary services, such as specialist consultation, local surgeries, emergency care, diagnostics/imaging services, and acute treatment; and tertiary care services, as well as operates quaternary hospitals. In addition, it provides a range of ancillary services, including laboratory and pathology services, physiotherapy and rehab, emergency help and transportation, home health services, hospital project manageme...
Jalan Stesen Sentral 5
Kuala Lumpur Sentral
Kuala Lumpur, 50470
Key Executives for IHH Healthcare Berhad
IHH Healthcare Berhad does not have any Key Executives recorded.
IHH Healthcare Berhad Key Developments
IHH Healthcare Berhad Reports Unaudited Consolidated Earnings Results for the Third Quarter and Nine Months Ended September 30, 2013
Nov 26 13
IHH Healthcare Berhad reported unaudited consolidated earnings results for the third quarter and nine months ended September 30, 2013. For the quarter, the company's revenue was MYR 1.7 billion compared with MYR 1.5 billion a year ago. The increase in the revenue was attributed to organic growth of existing operations and ramping up of new hospitals. Profit before tax was MYR 0.17 billion compared with MYR 0.12 billion a year ago. Profit attributable to owners of the company was MYR 0.12 billion or 1.43 sen per diluted share compared with MYR 0.07 billion or 0.95 sen per diluted share a year ago. As on September 30, 2013, the company's net assets per share attributable to owners of the company was MYR 2.20. EBITDA was MYR 0.39 million compared with MYR 0.42 billion a year ago.
For the nine months, the company's revenue was MYR 4.98 billion compared with MYR 5.4 billion a year ago. Profit before tax was MYR 0.59 billion compared with MYR 0.84 billion a year ago. Profit attributable to owners of the company was MYR 0.4 billion or 4.92 sen per diluted share compared with MYR 0.59 billion or 8.94 sen per diluted share a year ago. The decrease in the revenue and profit for the period were due to recognition of profit from sale of medical suites at Mount Elizabeth Novena Specialist Centre upon its completion in the second quarter of last year. EBITDA was MYR 1.21 billion compared with MYR 1.21 billion a year ago. Net cash generated from operating activities was MYR 0.84 billion compared with MYR 1.2 billion a year ago. Purchase of property, plant and equipment was MYR 1.12 billion compared with MYR 0.78 billion a year ago. Development and purchase of intangible assets was MYR 0.01 billion compared with MYR 0.004 billion a year ago.
IHH Healthcare Berhad to Report Q3, 2013 Results on Nov 26, 2013
Nov 20 13
IHH Healthcare Berhad announced that they will report Q3, 2013 results on Nov 26, 2013
IHH Healthcare Berhad Presents at UBS Asia Healthcare CEO Summit, Nov-01-2013 10:10 AM
Oct 31 13
IHH Healthcare Berhad Presents at UBS Asia Healthcare CEO Summit, Nov-01-2013 10:10 AM. Venue: The Ritz-Carlton, Hong Kong. Speakers: Lim Cheok Peng, Managing Director.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|